AI Science Tracker
EN

Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

1 discovery from 2023

Discoveries

Incremental value of radiomics with machine learning to the existing prognostic models for predicting outcome in renal cell carcinoma

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Across 689 patients, the radiomics nomogram added prognostic value over existing clinical models.

Technology: Random forest and LASSO-Cox selected CT radiomics for a renal-cell-carcinoma survival nomogram.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Random forest and LASSO-Cox selected CT radiomics for a renal-cell-carcinoma survival nomogram.
Limitation / still unknown
Training plus two validation cohorts and survival discrimination/calibration analyses; retrospective result does not establish treatment benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1036734/full · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1036734/full#s2 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1036734/full#s3–s4 · https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1036734/full#s2–s4 · https://pubmed.ncbi.nlm.nih.gov/37188171/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.